Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

165
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
09/24/2014 09/25/2014 09/26/2014 09/29/2014 09/30/2014 Date
87.9(c) 88.4(c) 88.3(c) 89.1(c) 90.15(c) Last
4 526 252 4 985 815 3 620 932 3 986 919 5 620 323 Volume
+0.17% +0.57% -0.11% +0.91% +1.18% Change
More quotes
Company
Novartis AG manufactures and markets health care and nutritional products.It provides innovative healthcare solutions and offers innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products.The company... 
Sector
Pharmaceuticals
Calendar
10/28Earnings Release
Surperformance© rating of Novartis AG
Trading Rating : Investor Rating :
More about the company
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 59 096 M
EBIT 2014 13 768 M
Net income 2014 10 500 M
Debt 2014 4 428 M
Yield 2014 2,88%
Sales 2015 57 971 M
EBIT 2015 14 514 M
Net income 2015 11 593 M
Debt 2015 7 955 M
Yield 2015 3,11%
PER 2014 22,19
PER 2015 20,12
EV / Sales 2014 4,41x
EV / Sales 2015 4,56x
Capitalization 256 479 M
More Financials
Latest news on NOVARTIS AG
30m ago Plant-based vaccines challenge big pharma for $3 billion flu market
35m ago NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
44m ago NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
48m ago NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
1d ago NESTLERFD : VEU, SRTY: Big ETF Inflows
1d ago NOVARTIS : Alcon Research Assigned Patent
2d ago NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
2d ago NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
2d ago NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
2d ago NOVARTIS : drug Signifor LAR recommended by CHMP for EU approval to treat patien..
2d ago NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
3d ago NOVARTIS : Eye Surgery Equipment Sought by Veterans Affairs
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF